Avadel Pharmaceuticals (AVDL) Tax Provisions (2016 - 2020)
Historic Tax Provisions for Avadel Pharmaceuticals (AVDL) over the last 12 years, with Q4 2020 value amounting to -$2.9 million.
- Avadel Pharmaceuticals' Tax Provisions rose 6830.05% to -$2.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$11.6 million, marking a year-over-year decrease of 11652.35%. This contributed to the annual value of -$12.1 million for FY2020, which is 12610.16% down from last year.
- Per Avadel Pharmaceuticals' latest filing, its Tax Provisions stood at -$2.9 million for Q4 2020, which was up 6830.05% from -$5.0 million recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' Tax Provisions registered a high of $13.3 million during Q4 2016, and its lowest value of -$14.5 million during Q4 2018.
- For the 5-year period, Avadel Pharmaceuticals' Tax Provisions averaged around $1.6 million, with its median value being $2.2 million (2019).
- In the last 5 years, Avadel Pharmaceuticals' Tax Provisions crashed by 66791.72% in 2018 and then surged by 62076.02% in 2019.
- Avadel Pharmaceuticals' Tax Provisions (Quarter) stood at $13.3 million in 2016, then crashed by 80.83% to $2.6 million in 2017, then plummeted by 667.92% to -$14.5 million in 2018, then soared by 38.09% to -$9.0 million in 2019, then soared by 68.3% to -$2.9 million in 2020.
- Its Tax Provisions was -$2.9 million in Q4 2020, compared to -$5.0 million in Q3 2020 and $5.3 million in Q2 2020.